The deletion of two cancer genes, CHD1 and MAP3K7, improves how well tumors respond to cancer immunotherapy and could be used ...
The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...
Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company's AI-enabled radiology ...
Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. | Microsoft ...
Dr. William A. Hall sat down with CURE to discuss the impact of technologies like artificial intelligence on gastrointestinal ...
A simple blood test can help detect cancer in patients with non-specific symptoms such as fatigue, pain or weight loss. This ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...
NEW YORK, NY, UNITED STATES, January 6, 2026 / EINPresswire.com / — Panther Life Sciences announces expanded access to its ...
"Reading demographics from a pathology slide is thought of as a 'mission impossible' for a human pathologist, so the bias in pathology AI was a surprise to us." To conduct the study, researchers at ...
The Dana-Farber Cancer Institute, one of the nation’s top cancer centers, has agreed to pay $15 million to settle fraud allegations, including its scientists’ use of inaccurate or altered data and ...
Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics
Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how advanced artificial intelligence and population health analytics can identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback